Showing results (1541-1550 of 6,770) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|November 26, 2025
Bioequivalence and Safety Study of Ranolazine Extended-Release Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions: A Randomized, Open-Label, Single-Dose, Cross-Over, Comparative Pharmacokinetic StudyXing Chen, Yaming Li, Genshan MaClinical Therapeutics|November 24, 2025
Increased Bone Mineral Content in Response to Electrical StimulationAlain S Comtois, James A Hodgdon, Jean P BoucherClinical Therapeutics|November 21, 2025
Impact of Crrt Timing on Mortality in Oliguric Sepsis-Associated Acute Kidney Injury: A Propensity Score Matching Cohort StudyJing Li, Caiyun Xu, Zhe Huang, et al.Clinical Therapeutics|January 9, 2026
Pharmacokinetic Equivalence of AmphosomTM, a Newly Developed Liposomal Amphotericin B, to AmbisomeⓇSeunghoon Han, Dong-Seok Yim, Sungpil Han, et al.Clinical Therapeutics|July 8, 2025
A Multilateral Qualitative Study of Perspectives on Enhancing Clinical Trial Diversity Among Historically Underrepresented GroupsMatthew J DePuccio, Daniel Torrez, Elizabeth Hsu, et al.Clinical Therapeutics|September 19, 2025
Anticancer Drugs Associated With Tumor Lysis Syndrome: Insights From the US Food and Drug Administration Adverse Event Reporting SystemWei Wang, Zirui Dong, Qi Miao, et al.Clinical Therapeutics|May 25, 2025
Comparative Efficacy and Safety of Short- Versus Standard-course Fluoroquinolone Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Meta-analysis of Double-blind StudiesSalma Messous, Achraf Rekik, Lynn Keraani, et al.Clinical Therapeutics|July 11, 2025
Effect of Intravenous Immunoglobulin or Plasmapheresis in Myasthenic Crisis and Worsening Myasthenia Gravis Compared With or Without Rescue TreatmentJayantee Kalita, Nagendra B Gutti, Faim Ahamed, et al.Clinical Therapeutics|July 27, 2025
Access to EU-Authorized Nonreimbursed Anticancer Medicines: An Explorative Survey Among Dutch Medical OncologistsH Colinda Post, Charlotte H C Bomhof, Maartje Schermer, et al.Clinical Therapeutics|July 26, 2025
Effects of Vunakizumab Treatment on Detailed Dimensions of Patient-Reported Outcomes in Moderate-to-Severe Plaque Psoriasis Patients: A Post-Hoc Analysis of a Randomized Controlled Trial (NCT04839016)Lijing Lv, Yan ZhangPageof 677